心脉医疗(688016.SH)：获得医疗器械注册证

Core Viewpoint - The company, Xinmai Medical (688016.SH), has received a medical device registration certificate from the National Medical Products Administration for its polyethylene glycol embolization microspheres, marking a significant advancement in interventional oncology treatment options [1] Group 1: Product Development - The polyethylene glycol embolization microspheres, named FinderSphere®/Night Pearl™, are the company's first embolization product developed for interventional oncology [1] - This product aims to provide more precise and efficient treatment options for Transarterial Chemoembolization (TACE) procedures, benefiting a larger number of cancer patients in China [1] Group 2: Existing and Pipeline Products - In addition to the new product, the company has already launched the Tipspear®/Piercing Arrow™ transjugular intrahepatic portosystemic shunt (TIPS) kit in China [1] - The company is also developing several other products in the interventional oncology field, including the innovative medical device HepaFlow®/Bridge to the Sky™ TIPS covered stent system, as well as hemostatic occlusion systems and microcatheters [1] Group 3: Future Commitment - The company is committed to the innovative research and application promotion of high-end medical devices in aortic, peripheral vascular, and interventional oncology fields, aiming to benefit more patients both domestically and internationally [1]